Together with the World Health Organization (WHO), Costa Rica has raised its voice to the world by requesting equitable, universal, urgent and quality access to health technologies with a “Call for Solidarity in Action” and making a request for the voluntary participation of all interested parties.
The President of the Republic, Carlos Alvarado, made a pre-launch of the proposal “Call to Solidarity in Action” (“Solidarity in Action Call”) at a virtual press conference this Friday in which the WHO Director-General participated. , Tedros Adhanom Ghebreyesus; and a representative from Chile, a country that has joined the initiative.
The official launch is scheduled for May 29 at the headquarters of the World Health Organization (WHO), in Geneva, Switzerland.
President Alvarado appealed to private companies, pharmaceuticals and manufacturers of health technologies, international organizations and civil society organizations, to support this Costa Rican commitment to solidarity and cooperation.
“It is time to be more united than ever, we have an unprecedented enemy and this is why we must face it with different and innovative solutions. I urge the governments of the world to voluntarily facilitate the open exchange of knowledge through international collaboration to guarantee the availability, affordability and guaranteed quality of health products, “added the president.
On the other hand, Dr. Tedros recognized the great commitment and leadership shown by the Costa Rican president and asked the other countries to join the initiative.
Costa Rica’s proposal calls for ensuring that the results of publicly funded research are available and accessible to the entire world population, through appropriate provisions in legally binding funding agreements, and that specific provisions on the affordability of COVID-19 related health products through voluntary licenses.
The President of Costa Rica asked the holders of intellectual property rights for therapies, diagnoses and vaccines, existing or new, related to COVID-19, to voluntarily grant urgent licenses for said rights on a non-exclusive basis to the Drug Patent Fund or other public health research and development mechanisms, consortia or initiatives that facilitate global and transparent access.
Finally, the Costa Rican president thanked the accompaniment of international organizations such as UNITAID, Medicines Patent Pool (MMP), UNDP and civil society organizations, whose contribution has been invaluable.
In addition to Ecuador and Chile, countries from various regions of the world have joined the initiative presented by our country.
Costa Rica’s proposal adheres to the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to make maximum use of the provisions of the Agreement on Aspects of Related Intellectual Property Rights with Commerce regarding flexibilities to protect public health and, in particular, provide access to medicines for all people.